The increasing interest in effective weight management has resulted in considerable research into groundbreaking treatments. Recently , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor activator , has exhibited positive results in clinical trials, implying potential for substantial weight decrease.